| Brand Name | Hattis Pharma |
|---|---|
| Industry / Business Category | Healthcare Products / Pharmaceutical Distribution |
| Founded Year | 2014 |
| Franchise Started Year | Not explicitly defined (pharma distribution expansion model) |
| Total Franchise Outlets | 100 – 200 |
| Estimated Investment | INR 10,000 – 50,000 |
| Franchise Fee | Typically part of onboarding and product licensing structure |
| Royalty Fee | Generally structured within product margins rather than fixed royalty |
| Space Requirement | 100 – 200 sq. ft. |
| Staff Requirement | 1–2 personnel for sales and inventory handling |
| Expected Payback Period | 1 – 2 Years |
Hattis Pharma is a pharmaceutical and healthcare products distribution franchise operating within the broader life sciences and pharma marketing sector. The business focuses on supplying medicines, nutraceuticals, and wellness products through a network of distributors and partners.
It functions as a product-based healthcare franchise, targeting medical professionals, chemists, and healthcare providers.
The model operates through a distribution and sales-driven system rather than a retail walk-in format.
The portfolio spans multiple therapeutic and wellness categories.
This diversified range enables multi-category sales within the healthcare ecosystem.
The franchise operates as a distribution and marketing partnership model.
This model aligns with typical pharma franchise (PCD) systems, where success depends on network building.
The investment requirement ranges from INR 10,000 to 50,000, making it a low-entry healthcare franchise.
The model is designed for low overhead and operational simplicity.
Support focuses on enabling effective product promotion and distribution.
These systems help franchise partners build credibility in the healthcare network.
Hattis Pharma has evolved from a small product portfolio into a broader life sciences business.
The brand’s expansion strategy is based on scaling through distributed sales networks rather than centralized retail.
This opportunity is suitable for:
Entrepreneurs exploring pharmaceutical and healthcare distribution franchises may also consider:
These companies operate in similar pharmaceutical and healthcare product segments, offering comparable distribution-driven opportunities.
The investment typically ranges between INR 10,000 and 50,000. This includes initial product stock, basic setup, and working capital. Compared to retail or manufacturing franchises, this model has a significantly lower entry cost.
The business operates through a distribution model where the franchise partner promotes and sells pharmaceutical products to doctors, clinics, and pharmacies. Revenue is generated through product margins and repeat orders from healthcare providers.
A small space of 100 to 200 square feet is sufficient. The setup is mainly for storing products and managing operations, rather than serving walk-in retail customers.
The expected payback period is around 1 to 2 years. Recovery depends on how quickly the franchise partner builds a strong network of doctors and pharmacies and generates consistent product orders.
Investors can apply by connecting with the company and completing onboarding formalities. This typically includes product training, territory allocation, and initial stock procurement before starting operations. ## Similar Franchise Opportunities